USPTO serial 79095162
VETCELL
Reviewed by CopyMark Law Group
Reg. 4239666Status 404
- Filing date
- Status date
- Registration date
- Nov 13, 2012
- Examiner
- LEE, DOUGLAS
- Law office
- TTAB
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VETCELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the cryo-preservation of cells, differentiated cells, stem cells and cells derived therefrom; chemicals for use in scientific research relating to the isolation, insertion, positioning and maintenance of differentiated cells, stem cells and cells derived therefrom | SECTION 18 - CANCELLED | — |
| 005 | Pharmaceutical and veterinary preparations for orthopaedic, ophthalmic, neurologic, oncologic and immunologic use; pharmaceutical and veterinary preparations for use in regenerative medicine for the treatment of orthopaedic, ophthalmic, neurologic, oncologic and immunologic damage, tendon and ligament damage and injuries, musculoskeletal damage and injuries; pharmaceuticals and veterinary preparations for the treatment of orthopaedic, ophthalmic, neurologic, oncologic and immunologic damage, tendon and ligament damage and injuries, musculoskeletal damage and injuries; chemical preparations adapted for pharmaceutical, medical and veterinary use for treatment of orthopaedic, ophthalmic, neurologic, oncologic and immunologic damage, tendon and ligament damage and injuries, musculoskeletal damage and injuries; differentiated cells, stem cells and cells derived there from for medical, veterinary or clinical use; stem cells for cellular therapeutics for medical, veterinary or clinical use; cryo-preserved stem cells; cell-derived preparations for medical, veterinary or clinical use; platelet rich plasma; growth factor preparations for injection for the treatment of orthopaedic, ophthalmic, neurologic, oncologic and immunologic damage, tendon and ligament damage and injuries, musculoskeletal damage and injuries; surgical implants comprising of living tissue, namely, bones and soft tissue, allogeneic bone graft material; medical plasters, wound dressings, medical dressings | SECTION 18 - CANCELLED | — |
| 010 | Surgical, medical, and veterinary apparatus and instruments for orthopaedic, ophthalmic, neurologic, oncologic and immunologic use; medical and veterinary apparatus and instruments for cryo-preservation of stem cells; surgical, medical and veterinary apparatus and instruments for use in the treatment of orthopaedic, ophthalmic, neurologic, oncologic and immunologic damage and injuries, tendon and ligament damage and injuries, musculoskeletal damage and injuries; surgical, medical and veterinary apparatus for use in the isolation, insertion, positioning and maintenance, including storage, of differentiated cells, stem cells and cells derived therefrom, cell-derived products and regenerative technology; artificial allogeneic bone graft material; ceramic bone graft substitute | SECTION 18 - CANCELLED | — |
| 042 | Scientific research and development services and design services for others in the field of orthopaedics, ophthalmics, neurology, oncology, immunology, regenerative medicine, differentiated cells, stem cells and cells derived there from, cellular and cell-derived therapeutics; veterinary and medical research services; scientific and industrial research in the field of orthopaedics, ophthalmics, neurology, oncology, immunology, regenerative medicine, differentiated cells, stem cells and cells derived there from, cellular and cell-derived therapeutics; scientific research and development services relating to regenerative medicine and technologies; scientific research and development relating to differentiated cells, stem cells and cells derived there from and cell-derived therapeutics; scientific research and development relating to cellular and cell-derived therapeutics; providing scientific and medical research information on pharmaceutical, medical and veterinary products and services through an on-line computer network | SECTION 18 - CANCELLED | — |
| 044 | Medical services; veterinary services: medical and veterinary services relating to the isolation,insertion, positioning, maintenance, and storage of differentiated cells, stem cells and cells derived therefrom, and cell-derived preparations, platelet rich plasma and growth factor injections; medical and veterinary consultancy services | SECTION 18 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Quy Biosciences Ltd.
- Other trademarks owned by Quy Biosciences Ltd.
- Other trademarks owned by Quy Biosciences Ltd.
- Other trademarks owned by ReCellerate, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named VETCELL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Nov 7, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Feb 5, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 5, 2019 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 2, 2018 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 2, 2018 | INPC | INVALIDATION PROCESSED | — |
| Nov 20, 2018 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 20, 2018 | C18. | CANCELLED SECTION 18-TOTAL | — |
| Mar 20, 2018 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Mar 20, 2018 | CANG | CANCELLATION GRANTED NO. 999999 | — |
| Oct 31, 2017 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| May 31, 2015 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 31, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 10, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 15, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 15, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 13, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 13, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 29, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 28, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 8, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 8, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 8, 2012 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 25, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 24, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 11, 2012 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 11, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 11, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 30, 2012 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 30, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 20, 2012 | PAPER RECEIVED | — | |
| Jan 11, 2012 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 10, 2012 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 5, 2012 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jan 5, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 20, 2011 | ALIE | ASSIGNED TO LIE | — |
| Dec 16, 2011 | PAPER RECEIVED | — | |
| Aug 6, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 17, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 17, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 17, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 16, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 19, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 15, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 14, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |